{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:20:43Z","timestamp":1787847643704,"version":"build-2784847793"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age group, but it affects women's health and quality of life across the life course. During different stages of life, the PCOS phenotype can change, which requires a personalized diagnostic approach and treatment. With increasing age, the syndrome evolves from a reproductive disease to a more metabolic disorder. Along with various metabolic disturbances like insulin resistance and abnormalities of energy expenditure, PCOS is recognized as a major risk factor for the development of type 2 diabetes and cardiovascular disease (CVD) in later life. The aim of the current review was to conduct a nonsystematic review of published literature and research that has been presented so far regarding menopausal women with PCOS as well as the associated changes in hormone profile, their lipid profile, and various metabolic changes that occur. The current review may also contribute to raise awareness about the risk of hypertension and CVDs in postmenopausal women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmh.jmh_8_21","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T04:36:19Z","timestamp":1618634179000},"page":"3-7","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Polycystic Ovarian Syndrome and Menopause in Forty Plus Women"],"prefix":"10.4103","volume":"12","author":[{"given":"Sudhaa","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240906","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","article-title":"Polycystic ovary syndrome: An ancient disorder?","volume":"95","author":"Azziz","year":"2011","journal-title":"Fertil Steril"},{"key":"R2-2-20240906","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"20","author":"Rocha","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R3-2-20240906","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R4-2-20240906","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2013.828687","article-title":"Polycystic ovaries \u2013 Beyond menopause","volume":"17","author":"Shah","year":"2014","journal-title":"Climacteric"},{"key":"R5-2-20240906","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/REP-14-0499","article-title":"Pathogenesis of polycystic ovary syndrome: Multifactorial assessment from the foetal stage to menopause","volume":"150","author":"de Melo","year":"2015","journal-title":"Reproduction"},{"key":"R6-2-20240906","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cyto.2015.06.008","article-title":"Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome","volume":"76","author":"S\u00f3ter","year":"2015","journal-title":"Cytokine"},{"key":"R7-2-20240906","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.90208.2008","article-title":"Transient prenatal androgen exposure produces metabolic syndrome in adult female rats","volume":"295","author":"Demissie","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R8-2-20240906","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"R9-2-20240906","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Erhmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-2-20240906","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000098956","article-title":"Morphological and morphometric analysis of the adrenal cortex of androgenized female rats","volume":"64","author":"da Silva","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"R11-2-20240906","first-page":"142","article-title":"The polycystic ovary syndrome: An update on metabolic and hormonal mechanisms","volume":"8","author":"Dumitrescu","year":"2015","journal-title":"J Med Life"},{"key":"R12-2-20240906","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","article-title":"The inflammatory markers in polycystic ovary syndrome: Association with obesity and IVF outcomes","volume":"39","author":"\u00c7ak\u0131ro\u011flu","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R13-2-20240906","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: An update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"R14-2-20240906","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","article-title":"Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters","volume":"40","author":"Durmus","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"R15-2-20240906","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical practice. Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"R16-2-20240906","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"R17-2-20240906","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"R18-2-20240906","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/JOE-16-0405","article-title":"Hormonal alterations in PCOS and its influence on bone metabolism","volume":"232","author":"Krishnan","year":"2017","journal-title":"J Endocrinol"},{"key":"R19-2-20240906","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10641961003628536","article-title":"Evaluation of arterial blood pressure and renal sodium handling in a model of female rats in persistent estrus","volume":"32","author":"Rocha Gontijo","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"R20-2-20240906","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: Current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int J Womens Health"},{"key":"R21-2-20240906","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"R22-2-20240906","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.fertnstert.2008.02.167","article-title":"Insulin resistance directly contributes to androgenic potential within ovarian theca cells","volume":"91","author":"Qu","year":"2009","journal-title":"Fertil Steril"},{"key":"R23-2-20240906","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.fertnstert.2010.07.1090","article-title":"Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro","volume":"95","author":"Zhao","year":"2011","journal-title":"Fertil Steril"},{"key":"R24-2-20240906","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-2-20240906","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: Polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"R26-2-20240906","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health \u2013 National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-2-20240906","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2009-0740","article-title":"Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease","volume":"94","author":"Patel","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-2-20240906","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition","volume":"85","author":"Burger","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-2-20240906","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/dmm020","article-title":"A review of hormonal changes during the menopausal transition: Focus on findings from the Melbourne Women's Midlife Health Project","volume":"13","author":"Burger","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R30-2-20240906","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2008-0701","article-title":"Adipokines, inflammation, and visceral adiposity across the menopausal transition: A prospective study","volume":"94","author":"Lee","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-2-20240906","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R32-2-20240906","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2002-021549","article-title":"Ovarian age-related responsiveness to human chorionic gonadotropin","volume":"88","author":"Piltonen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-2-20240906","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1210\/jc.2003-031851","article-title":"Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome","volume":"89","author":"Piltonen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-2-20240906","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2008-2583","article-title":"Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome","volume":"94","author":"Puurunen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-2-20240906","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/1570161116666180904094149","article-title":"Metabolic syndrome during menopause","volume":"17","author":"Mumusoglu","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"R36-2-20240906","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"Puurunen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-2-20240906","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","article-title":"Is polycystic ovary syndrome an exception for reproductive aging?","volume":"25","author":"Tehrani","year":"2010","journal-title":"Hum Reprod"},{"key":"R38-2-20240906","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-M\u00fcllerian hormone and folliculogenesis","volume":"234","author":"Visser","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"R39-2-20240906","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/aogs.13489","article-title":"Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls","volume":"98","author":"Forslund","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R40-2-20240906","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13697137.2017.1392501","article-title":"Prediction of age at menopause in women with polycystic ovary syndrome","volume":"21","author":"Minooee","year":"2018","journal-title":"Climacteric"},{"key":"R41-2-20240906","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-2-20240906","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): A 21-year followup study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-2-20240906","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: Evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"R44-2-20240906","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2298\/VSP0206593M","article-title":"Age and body mass related changes of cardiovascular risk factors in women with polycystic ovary syndrome","volume":"59","author":"Macut","year":"2002","journal-title":"Vojnosanit Pregl"},{"key":"R45-2-20240906","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R46-2-20240906","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol (Oxf"},{"key":"R47-2-20240906","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0015-0282(00)00695-6","article-title":"Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?","volume":"74","author":"Loucks","year":"2000","journal-title":"Fertil Steril"},{"key":"R48-2-20240906","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R49-2-20240906","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb"},{"key":"R50-2-20240906","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/humrep\/det119","article-title":"Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors","volume":"28","author":"Carmina","year":"2013","journal-title":"Hum Reprod"},{"key":"R51-2-20240906","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0030-1269882","article-title":"Menstrual irregularities in PCOS. DoeE it matter when it starts?","volume":"119","author":"Livadas","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R52-2-20240906","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: A 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-2-20240906","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: A retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf"},{"key":"R54-2-20240906","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MED.0b013e32833ab083","article-title":"Androgen deficiency and therapy in women","volume":"17","author":"Mathur","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Journal of Mid-life Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmh.jmh_8_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:26:00Z","timestamp":1787844360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmh.jmh_8_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jmh.jmh_8_21","relation":{},"ISSN":["0976-7800"],"issn-type":[{"value":"0976-7800","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}